YD Bio Limited YDES
Updated: 8 Aug 2026
No signal published yet
We already track YD Bio and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow YD Bio Limited? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow YD Bio free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
In August 2026, YD Bio highlighted a peer-reviewed publication on a new computational framework for keratoconus research. In July 2026, the company launched a cross-border cancer testing pilot in Canada in partnership with Numia Health.
What Firelda Watch includes for YD Bio Limited
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow YD Bio Limited? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow YD Bio free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more